Regulations.gov document
Identification of Alternative In Vitro Bioequivalence Pathways Which Can Reliably Ensure…
Notice · FDA-2015-N-0684 · posted Oct 2, 2015
Key facts
| Document ID | FDA-2015-N-0684-0012 |
|---|---|
| Title | Identification of Alternative In Vitro Bioequivalence Pathways Which Can Reliably Ensure In Vivo Bioequivalence of Product Performance and Quality of Non-Systemically Absorbed Drug Products for Animals; Reopening of the Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2015-N-0684 |
| Posted | Oct 2, 2015 |
| Federal Register citation | 80 FR 59787 |
| FR document number | 2015-25121 |
| Comment period opens | Oct 2, 2015 |
| Comments due | Nov 3, 2015 |
| Effective date | Oct 2, 2015 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: